Ultragenyx Pharmaceutical Inc (RARE) EVP and General Counsel Karah Herdman Parschauer Sold ...

- By insider

EVP and General Counsel of Ultragenyx Pharmaceutical Inc (30-Year Financial, Insider Trades) Karah Herdman Parschauer (insider trades) sold 10,000 shares of RARE on 09/23/2020 at an average price of $85 a share. The total sale was $850,000.

• Warning! GuruFocus has detected 3 Warning Sign with SAVA. Click here to check it out.

• RARE 15-Year Financial Data

• The intrinsic value of RARE

• Peter Lynch Chart of RARE

Ultragenyx Pharmaceutical Inc is biopharmaceutical company. It is engaged identification, acquisition, development and commercialization of novel products for treatment of rare & ultra-rare diseases, with a focus on debilitating genetic diseases. Ultragenyx Pharmaceutical Inc has a market cap of $4.85 billion; its shares were traded at around $80.01 with and P/S ratio of 29.67.

CEO Recent Trades:

• President & CEO Emil D Kakkis sold 30,000 shares of RARE stock on 09/01/2020 at the average price of $82.63. The price of the stock has decreased by 3.17% since.

Directors and Officers Recent Trades:

• EVP and General Counsel Karah Herdman Parschauer sold 10,000 shares of RARE stock on 09/23/2020 at the average price of $85. The price of the stock has decreased by 5.87% since.

For the complete insider trading history of RARE, click here

.This article first appeared on GuruFocus.